News Release

Use of cryopreserved oocytes in patients with poor ovarian response

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

About The Study: This study of 67,000 freezing cycles among 47,000 patients reveals a distinct pattern in the utilization of cryopreserved oocytes among patients undergoing planned oocyte cryopreservation in the U.S. Despite the increase in number of patients pursuing oocyte cryopreservation, there is a notably low rate of return to utilize previously vitrified oocytes; notably, patients with poor ovarian response are more likely to return, although the time to return is similar to those with normal ovarian response. 

Authors: Yuval Fouks, M.D., M.P.H., of Boston IVF-The Eugin Group in Waltham, Massachusetts, is the corresponding author. 

 To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.